Clinical Trials in New York

Showing 10481-10500 of 19,464 trials

Study of Safety and Efficacy of a rhPTH[1-84] of Fixed Doses of 25 and 50 mcg in Adults With Hypoparathyroidism (RELAY)

NCT01268098

Use of PTH (1-84) a recombinant hormone in 25 µg or 50 µg doses for the treatment of adults with hypoparathyroidism. The use of PTH (1-84) should result in a decrease of calcium and vitamin D supplements.

Hypoparathyroidism

Shire42 participantsStarted Feb 2011

Lakewood, California, United States • Chicago, Illinois, United States • Indianapolis, Indiana, United States +9 more locations

COMPLETEDPhase 2< 1 mile

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

NCT01620255

To determine the dose or doses of PF-00547659 that will be the most effective to improve or halt the disease symptoms in patients with moderate to severe ulcerative colitis.

Ulcerative Colitis

Shire357 participantsStarted Nov 2012

Scottsdale, Arizona, United States • La Jolla, California, United States • La Jolla, California, United States +187 more locations

Study of Safety and Efficacy of a rhPTH[1-84] of Fixed Doses of 25 and 50 mcg in Adults With Hypoparathyroidism (RELAY)

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Find Trials by Condition in New York

Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children

A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021

SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)

Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection

Study of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis (IPF)

World Trade Center Kidney-Link

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension

Prevention of COVID-19 Infection to Severe Pneumonia or ARDS

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms

Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis

Dose-Response Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A

Local Vasoconstriction in Postural Tachycardia Syndrome

Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Idursulfase

A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema

A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects

Double-blind, Placebo-controlled, Randomised Withdrawal, Extension, Safety and Efficacy Study of LDX in Children and Adolescents Aged 6-17